June 22, 2023

IUCT-Oncopole and Cell-Easy sign a MOU to accelerate cancer patient access to advanced cell-based therapy

TOULOUSE, FRANCE, June 22, 2023  IUCT-Oncopole and Cell-Easy SAS (Cell-Easy) announced today the signing of a Memorandum of Understanding to enhance their strategic collaborative relationship and open access to advanced cell-based therapies. This partnership aims to drive innovation in public health and improve access to promising new cancer therapies for patients.   By

+ Read More

your CDMO Partner for Cell Therapy

Keep in touch
Linkedin

Cell-Easy

4 Bis avenue Hubert Curien

31100 Toulouse,

FRANCE

Science-driven CDMO specialized in Cell Therapy, Cell-Easy offers customized process development, GMP manufacturing and analytical services for immune cells and adult stem cells in Immuno-oncology and Regenerative Medicine fields.

Privay Policy